Jeffery G. Derge - Concepedia

Concepedia

Author

Jeffery G. Derge

National Institutes of Health

Also Known As

J. G. Derge, JEFFERY G. DERGE, Jeffery G Derge, Jeffery G. Derge

14

Publications

1.2K

Citations

12

H-Index

25

Concepts

All Affiliations

National Institutes of Health National Cancer Institute Flow Pharma (United States)University of Illinois Chicago

JG

About

Jeffery G. Derge is an author at National Institutes of Health specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	401
2	Immunology	7	7	390
3	Cell Biology	3	3	273
4	Natural Sciences	1	1	11
5	Biochemistry	1	1	11

Jeffery G. Derge

×

13

Publications

1.2K

Citations

12

H-Index

	Year	Citations
The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC) Daniela S. Gerhard, Lukas Wagner, Elise A. Feingold, Genome Research	2004	586
Synthesis of Epstein-Barr Virus After Activation of the Viral Genome in a “Virus-Negative” Human Lymphoblastoid Cell (Raji) Made Resistant to 5-Bromodeoxyuridine Berge Hampar, Jeffery G. Derge, Lidia M. Martos, Proceedings of the National Academy of Sciences Viral ReplicationImmunologyPathologyRaji LineImmunotherapy	1972	198
Replication of the Resident Repressed Epstein-Barr Virus Genome During the Early S Phase (S-1 Period) of Nonproducer Raji Cells Berge Hampar, Akiko Tanaka, Meihan Nonoyama, Proceedings of the National Academy of Sciences	1974	88
Identification of a Critical Period during the S Phase for Activation of the Epstein-Barr Virus by 5-Iododeoxyuridine Berge Hampar, Jeffery G. Derge, Lidia M. Martos, Nature New Biology Epstein-barr VirusPathogenesisImmunologyPathologyVirology	1973	65
Persistence of a Repressed Epstein-Barr Virus Genome in Burkitt Lymphoma Cells Made Resistant to 5-Bromodeoxyuridine Berge Hampar, Jeffery G. Derge, Lidia M. Martos, Proceedings of the National Academy of Sciences	1971	52
Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine Berge Hampar, Jeffery G. Derge, Meihan Nonoyama, Virology Epstein-barr Virus-activated CellsNeurovirologyImmunologyAntiviral ResponseImmunotherapy	1974	41
Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine Berge Hampar, Gilbert Lenoir, Meihan Nonoyama, Virology Molecular VirologyCell Cycle DependenceEpstein-barr VirusImmunologyAntiviral Drug Development	1976	34
Sequence of Spontaneous Epstein-Barr Virus Activation and Selective DNA Synthesis in Activated Cells in the Presence of Hydroxyurea Berge Hampar, Jeffery G. Derge, Lidia M. Martos, Proceedings of the National Academy of Sciences	1972	33
Procedure for Activating Epstein-Barr Virus Early Antigen in Nonproducer Cells by 5-Iododeoxyuridine Cedric W. Long, Jeffery G. Derge, Berge Hampar JNCI Journal of the National Cancer Institute ImmunohematologyNational Cancer InstituteApril 1974Viral PersistenceImmunodeficiencies	1974	24
Activation of endogenous type C virus in BALB/c mouse cells by herpesvirus DNA Ann L. Boyd, Jeffery G. Derge, Berge Hampar Proceedings of the National Academy of Sciences	1978	19

Page 1